☰

Maximilian Diehn, Ph.D. - Publications

Affiliations: 
2004 Stanford University, Palo Alto, CA 
Area:
gene expression
Tree Info Grants Similar researchers PubMed Report error

248 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Alig SK, Esfahani MS, Garofalo A, Li MY, Rossi C, Flerlage T, Flerlage JE, Adams R, Binkley MS, Shukla N, Jin MC, Olsen M, Telenius A, Mutter JA, Schroers-Martin JG, ... ... Diehn M, et al. Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling. Nature. PMID 38081297 DOI: 10.1038/s41586-023-06903-x  0.309
2022 Spurr LF, Martinez CA, Kang W, Chen M, Zha Y, Hseu R, Gutiontov SI, Turchan WT, Lynch CM, Pointer KB, Chang P, Murgu S, Husain AN, Cody B, Vokes EE, ... ... Diehn M, et al. Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade. Nature Cancer. PMID 36443406 DOI: 10.1038/s43018-022-00467-x  0.313
2022 Nair VS, Hui AB, Chabon JJ, Shahrokh Esfahani M, Stehr H, Nabet BY, Zhou L, Chaudhuri AA, Benson JA, Ayers K, Bedi H, Ramsey MC, Van Wert R, Antic S, Lui NS, ... ... Diehn M, et al. Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer. Cancer Research. PMID 35748739 DOI: 10.1158/0008-5472.CAN-22-0554  0.356
2022 Esfahani MS, Hamilton EG, Mehrmohamadi M, Nabet BY, Alig SK, King DA, Steen CB, Macaulay CW, Schultz A, Nesselbush MC, Soo J, Schroers-Martin JG, Chen B, Binkley MS, Stehr H, ... ... Diehn M, et al. Inferring gene expression from cell-free DNA fragmentation profiles. Nature Biotechnology. PMID 35361996 DOI: 10.1038/s41587-022-01222-4  0.327
2021 Moding EJ, Nabet BY, Alizadeh AA, Diehn M. Detecting Liquid Remnants of Solid Tumors: Circulating Tumor DNA Minimal Residual Disease. Cancer Discovery. PMID 34785539 DOI: 10.1158/2159-8290.CD-21-0634  0.307
2020 Moding EJ, Liu Y, Nabet BY, Chabon JJ, Chaudhuri AA, Hui AB, Bonilla RF, Ko RB, Yoo CH, Gojenola L, Jones CD, He J, Qiao Y, Xu T, Heymach JV, ... ... Diehn M, et al. Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer. Nature Cancer. 1: 176-183. PMID 34505064 DOI: 10.1038/s43018-019-0011-0  0.306
2020 Hellyer JA, Padda SK, Diehn M, Wakelee HA. Clinical implications of KEAP1-NFE2L2 mutations in non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 33307193 DOI: 10.1016/j.jtho.2020.11.015  0.318
2020 Accomando WP, Rao AR, Hogan DJ, Newman AM, Nakao A, Alizadeh AA, Diehn M, Diago OR, Gammon DK, Haghighi A, Gruber HE, Jolly DJ, Ostertag D. Molecular and immunological signatures are related to clinical benefit from treatment with Vocimagene amiretrorepvec (Toca 511) and 5-fluorocytosine (Toca FC) in patients with glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32816892 DOI: 10.1158/1078-0432.Ccr-20-0536  0.406
2020 Dasari A, Morris VK, Allegra CJ, Atreya C, Benson AB, Boland P, Chung K, Copur MS, Corcoran RB, Deming DA, Dwyer A, Diehn M, Eng C, George TJ, Gollub MJ, et al. ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper. Nature Reviews. Clinical Oncology. PMID 32632268 DOI: 10.1038/S41571-020-0392-0  0.329
2020 Binkley MS, Koenig JL, Kashyap M, Xiang M, Liu Y, Sodji Q, Maxim PG, Diehn M, Loo BW, Gensheimer MF. Predicting per-lesion local recurrence in locally advanced non-small cell lung cancer following definitive radiation therapy using pre- and mid-treatment metabolic tumor volume. Radiation Oncology (London, England). 15: 114. PMID 32429982 DOI: 10.1186/S13014-020-01546-Y  0.408
2020 Gentles AJ, Hui AB, Feng W, Azizi A, Nair RV, Bouchard G, Knowles DA, Yu A, Jeong Y, Bejnood A, Forgó E, Varma S, Xu Y, Kuong A, Nair VS, ... ... Diehn M, et al. A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk. Genome Biology. 21: 107. PMID 32381040 DOI: 10.1186/S13059-020-02019-X  0.383
2020 Chabon JJ, Hamilton EG, Kurtz DM, Esfahani MS, Moding EJ, Stehr H, Schroers-Martin J, Nabet BY, Chen B, Chaudhuri AA, Liu CL, Hui AB, Jin MC, Azad TD, Almanza D, ... ... Diehn M, et al. Integrating genomic features for non-invasive early lung cancer detection. Nature. 580: 245-251. PMID 32269342 DOI: 10.1038/S41586-020-2140-0  0.579
2020 Phillips R, Shi WY, Deek M, Radwan N, Lim SJ, Antonarakis ES, Rowe SP, Ross AE, Gorin MA, Deville C, Greco SC, Wang H, Denmeade SR, Paller CJ, Dipasquale S, ... ... Diehn M, et al. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial. Jama Oncology. PMID 32215577 DOI: 10.1001/Jamaoncol.2020.0147  0.502
2020 Hellmann MD, Nabet BY, Rizvi H, Chaudhuri AA, Wells DK, Dunphy MP, Chabon JJ, Liu CL, Hui AB, Arbour KC, Luo J, Preeshagul IR, Moding EJ, Almanza D, Bonilla RF, ... ... Diehn M, et al. Circulating tumor DNA analysis to assess risk of progression after long-term response to PD-(L)1 blockade in NSCLC. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32046999 DOI: 10.1158/1078-0432.Ccr-19-3418  0.544
2020 Newman AM, Nakao A, Li K, Wilson DC, Liu C, Diehn M, Alizadeh AA. Analytical validation of iSort digital cytometry for leukocyte enumeration in clinical tumor specimens. Journal of Clinical Oncology. 38: e15243-e15243. DOI: 10.1200/Jco.2020.38.15_Suppl.E15243  0.583
2020 Murciano-Goroff YR, Hui AB, Chabon JJ, Moding EJ, Lebow ES, Araujo-Filho JA, Isbell JM, Jones DR, Ginsberg MS, Myers ML, Offin M, Drilon AE, Hellmann MD, Lai WV, Reis-Filho JS, ... ... Diehn M, et al. Early ctDNA response assessment for prediction of platinum sensitivity in small cell lung cancer. Journal of Clinical Oncology. 38: 9067-9067. DOI: 10.1200/Jco.2020.38.15_Suppl.9067  0.581
2020 Moding EJ, Esfahani MS, Nabet B, Liu Y, Chabon JJ, He J, Qiao Y, Xu T, Yao L, Gandhi S, Liao ZX, Das M, Ramchandran K, Padda SK, Neal JW, ... ... Diehn M, et al. A mid-chemoradiation dynamic risk model integrating tumor features and ctDNA analysis for lung cancer outcome prediction. Journal of Clinical Oncology. 38: 9046-9046. DOI: 10.1200/Jco.2020.38.15_Suppl.9046  0.582
2020 Binkley MS, Jeon Y, Nesselbush M, Moding EJ, Nabet B, Almanza DS, Yoo C, Kurtz DM, Owen SG, Backhus LM, Berry MF, Shrager JB, Ramchandran K, Padda SK, Das M, ... ... Diehn M, et al. KEAP1/NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer. Journal of Clinical Oncology. 38: 9012-9012. DOI: 10.1200/Jco.2020.38.15_Suppl.9012  0.574
2020 Newman AM, Nakao A, Li K, Liu C, Mathi K, Sigal N, Maecker H, Diehn M, Alizadeh AA. Analytical validation of digital cytometry (iSort) for leukocyte enumeration using stored blood. Journal of Clinical Oncology. 38: 3542-3542. DOI: 10.1200/Jco.2020.38.15_Suppl.3542  0.51
2020 Nabet BY, Esfahani MS, Hamilton EG, Chabon JJ, Moding EJ, Rizvi H, Steen CB, Chaudhuri AA, Liu CL, Hui AB, Stehr H, Goljenola L, Jin MC, Jeon Y, Tseng D, ... ... Diehn M, et al. Abstract 5666: A noninvasive approach for early prediction of therapeutic benefit from immune checkpoint inhibition for lung cancer Tumor Biology. DOI: 10.1158/1538-7445.Am2020-5666  0.335
2020 Luca BA, Steen CB, Azizi A, Matusiak M, Przybyl J, Neishaboori N, Pérez AE, Diehn M, Alizadeh AA, Rijn Mvd, Gentles AJ, Newman AM. Abstract 3443: Atlas of clinically-distinct cell states and cellular ecosystems across human solid tumors Cancer Research. 80: 3443-3443. DOI: 10.1158/1538-7445.Am2020-3443  0.411
2020 Esfahani MS, Mehrmohamadi M, Steen CB, Hamilton EG, King DA, Soo J, Macaulay C, Jin M, Kurtz DM, Nabet B, Moding E, Chabon J, Newman A, Diehn M, Alizadeh AA. Abstract 3388: Chromatin accessibility patterns in cell-free DNA reveal tumor heterogeneity Cancer Research. 80: 3388-3388. DOI: 10.1158/1538-7445.Am2020-3388  0.462
2020 Steen CB, Luca B, Esfahani MS, Nabet BY, Sworder B, Farshidfar F, Kurtz D, Liu CL, Advani RH, Natkunam Y, Myklebust JH, Diehn M, Gentles A, Alizadeh A, Newman AM. Abstract 1557: Landscape of tumor cell states and cellular ecosystems in diffuse large B cell lymphoma Cancer Research. 80: 1557-1557. DOI: 10.1158/1538-7445.Am2020-1557  0.41
2020 Rahman SJ, Chu S, Zhao S, Zou Y, Hui A, Stricker T, Diehn M, Massion PP. Abstract 1137: Deep targeted and whole exome sequencing identifies driver mutations in the airway epithelium of individuals at high risk for lung cancer Cancer Research. 80: 1137-1137. DOI: 10.1158/1538-7445.Am2020-1137  0.397
2019 Esfahani MS, Lee LJ, Jeon YJ, Flynn RA, Stehr H, Hui AB, Ishisoko N, Kildebeck E, Newman AM, Bratman SV, Porteus MH, Chang HY, Alizadeh AA, Diehn M. Functional significance of U2AF1 S34F mutations in lung adenocarcinomas. Nature Communications. 10: 5712. PMID 31836708 DOI: 10.1038/S41467-019-13392-Y  0.62
2019 Baek S, He Y, Allen BG, Buatti JM, Smith BJ, Tong L, Sun Z, Wu J, Diehn M, Loo BW, Plichta KA, Seyedin SN, Gannon M, Cabel KR, Kim Y, et al. Deep segmentation networks predict survival of non-small cell lung cancer. Scientific Reports. 9: 17286. PMID 31754135 DOI: 10.1038/S41598-019-53461-2  0.389
2019 Azad TD, Chaudhuri AA, Fang P, Qiao Y, Esfahani MS, Chabon JJ, Hamilton EG, Yang YD, Lovejoy A, Newman AM, Kurtz DM, Jin M, Schroers-Martin J, Stehr H, Liu CL, ... ... Diehn M, et al. Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer. Gastroenterology. PMID 31711920 DOI: 10.1053/J.Gastro.2019.10.039  0.592
2019 Chen B, Khodadoust MS, Olsson N, Wagar LE, Fast E, Liu CL, Muftuoglu Y, Sworder BJ, Diehn M, Levy R, Davis MM, Elias JE, Altman RB, Alizadeh AA. Predicting HLA class II antigen presentation through integrated deep learning. Nature Biotechnology. PMID 31611695 DOI: 10.1038/S41587-019-0280-2  0.497
2019 Jeong Y, Hellyer JA, Stehr H, Hoang NT, Niu X, Das M, Padda SK, Ramchandran K, Neal JW, Wakelee HA, Diehn M. Role of KEAP1/NFE2L2 mutations in the chemotherapeutic response of non-small cell lung cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31548347 DOI: 10.1158/1078-0432.Ccr-19-1237  0.367
2019 Moding EJ, Liang R, Lartey FM, Maxim PG, Sung A, Diehn M, Loo BW, Gensheimer MF. Predictors of Respiratory Decline Following Stereotactic Ablative Radiotherapy to Multiple Lung Tumors. Clinical Lung Cancer. PMID 31377143 DOI: 10.1016/J.Cllc.2019.05.015  0.394
2019 Hellyer JA, Stehr H, Das M, Padda SK, Ramchandran K, Neal JW, Diehn M, Wakelee HA. Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 134: 42-45. PMID 31319993 DOI: 10.1016/J.Lungcan.2019.05.002  0.327
2019 Kurtz DM, Esfahani MS, Scherer F, Soo J, Jin MC, Liu CL, Newman AM, Dührsen U, Hüttmann A, Casasnovas O, Westin JR, Ritgen M, Böttcher S, Langerak AW, Roschewski M, ... ... Diehn M, et al. Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction. Cell. PMID 31280963 DOI: 10.1016/J.Cell.2019.06.011  0.548
2019 Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, Khodadoust MS, Esfahani MS, Luca BA, Steiner D, Diehn M, Alizadeh AA. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nature Biotechnology. PMID 31061481 DOI: 10.1038/S41587-019-0114-2  0.538
2019 Prionas ND, von Eyben R, Yi E, Aggarwal S, Shaffer J, Bazan J, Eastham D, Maxim PG, Graves EE, Diehn M, Gensheimer MF, Loo BW. Increases in Serial Pretreatment F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy. Advances in Radiation Oncology. 4: 429-437. PMID 31011689 DOI: 10.1016/J.Adro.2018.11.006  0.388
2019 Wang SXY, Zhang BM, Wakelee HA, Koontz MZ, Pan M, Diehn M, Kunder CA, Neal JW. Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib. Anti-Cancer Drugs. PMID 30762593 DOI: 10.1097/Cad.0000000000000765  0.372
2019 Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Newman AM, ... ... Diehn M, et al. Reply to J. Wang et al. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801907. PMID 30753108 DOI: 10.1200/Jco.18.01907  0.439
2019 Moding EJ, Liu Y, Nabet B, Chabon JJ, Chaudhuri A, Hui AB, He J, Qiao Y, Heymach J, Tsao AS, Liao ZX, Gomez DR, Ramchandran K, Neal JW, Wakelee HA, ... ... Diehn M, et al. ctDNA analysis for personalization of consolidation immunotherapy in localized non-small cell lung cancer. Journal of Clinical Oncology. 37: 2547-2547. DOI: 10.1200/Jco.2019.37.15_Suppl.2547  0.537
2019 Esfahani MS, Alig S, Kurtz DM, Soo J, Jin MC, Macaulay C, Craig AFM, Garofalo A, Steen CB, Scherer F, Sworder B, Diehn M, Alizadeh AA. Towards Non-Invasive Classification of DLBCL Genetic Subtypes By Ctdna Profiling Blood. 134: 551-551. DOI: 10.1182/Blood-2019-132069  0.508
2019 Garofalo A, Schroers-Martin JG, Soo J, Kurtz DM, Sworder B, Liu CL, Pinsky BA, Luikart H, Advani RH, Natkunam Y, Khush K, Diehn M, Alizadeh AA. Deep Sequencing of Viral Cell-Free DNA for Noninvasive Detection of Immunosuppression-Related Lymphoid Malignancies Blood. 134: 885-885. DOI: 10.1182/Blood-2019-131602  0.526
2019 Macaulay C, Alig S, Kurtz DM, Jin MC, Opat S, Soo J, Sworder B, Hertzberg MS, Gandhi MK, Diehn M, Alizadeh AA. Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL Blood. 134: 1600-1600. DOI: 10.1182/Blood-2019-131278  0.545
2019 Kurtz DM, Soo J, Alig S, Keh LCT, Macaulay C, Jin MC, Scherer F, Hamilton EG, Liu CL, Chen B, Craig AFM, Diehn M, Alizadeh AA. Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA Blood. 134: 552-552. DOI: 10.1182/Blood-2019-131267  0.571
2019 Steen CB, Luca BA, Esfahani MS, Nabet BY, Sworder B, Farshidfar F, Shamardani K, Kurtz DM, Liu CL, Advani RH, Natkunam Y, Myklebust JH, Diehn M, Gentles A, Newman AM, et al. An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma Blood. 134: 655-655. DOI: 10.1182/Blood-2019-129461  0.577
2019 Alig S, Macaulay C, Kurtz DM, Dührsen U, Hüttmann A, Jin MC, Sworder B, Garofalo A, Esfahani MS, Soo J, Scherer F, Craig A, Casasnovas O, Westin JR, Gaidano G, ... ... Diehn M, et al. Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin Lymphoma Blood. 134: 491-491. DOI: 10.1182/Blood-2019-129283  0.544
2019 Sworder B, Kurtz DM, Macaulay C, Frank MJ, Alig S, Garofalo A, Sahaf B, Esfahani MS, Spiegel JY, Oak J, Beygi S, Jin MC, Chabon JJ, Khodadoust MS, Majzner RG, ... ... Diehn M, et al. Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy Blood. 134: 550-550. DOI: 10.1182/Blood-2019-129015  0.578
2019 Moding E, Nabet B, Liu Y, Chabon J, Chaudhuri A, Hui A, Binkley M, He J, Qiao Y, Xu T, Yao L, Gandhi S, Liao Z, Das M, Ramchandran K, ... ... Diehn M, et al. Circulating Tumor DNA Changes During Chemoradiation for Lung Cancer Predict Patient Outcomes International Journal of Radiation Oncology*Biology*Physics. 105: S113. DOI: 10.1016/J.Ijrobp.2019.06.610  0.597
2019 Benson K, Sandhu N, Zhang C, Ko RB, Toesca DAS, Eyben RV, Diehn M, Bush K, Maxim PG, Gensheimer MF, Soltys SG, Loo BW, Pollom E, Chang DT. Outcomes of Oligometastatic Colorectal Cancer treated with Stereotactic Ablative Radiotherapy International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.2134  0.3
2019 Ko RB, Jani K, Sodji Q, Merriott DJ, Pickthorn W, Bush K, Maxim PG, Diehn M, Loo BW. Symptomatic Cardiac Events in Patients with Lung Tumors Near The Heart Treated with Stereotactic Ablative Radiotherapy (SABR): A Single Institution Experience International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.151  0.344
2019 Binkley MS, Stehr H, Moding EJ, Owen SG, Ko R, Maxim PG, Loo BW, Diehn M. Investigating and Validating Metabolic Tumor Volume As a Prognostic Factor for Local Recurrence in Early Stage Lung Cancer International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1407  0.384
2018 Dudley JC, Schroers-Martin J, Lazzareschi DV, Shi WY, Chen SB, Esfahani MS, Trivedi D, Chabon JJ, Chaudhuri AA, Stehr H, Liu CL, Lim H, Costa HA, Nabet BY, Sin MLY, ... ... Diehn M, et al. Detection and surveillance of bladder cancer using urine tumor DNA. Cancer Discovery. PMID 30578357 DOI: 10.1158/2159-8290.Cd-18-0825  0.567
2018 Nguyen KH, Stehr H, Zhou L, Nguyen AH, Hiep PN, Van Cau N, Duy PC, Thorp R, Wakelee HA, Diehn M, Neal JW. Comparison of Genomic Driver Oncogenes in Vietnamese Patients With Non-Small-Cell Lung Cancer in the United States and Vietnam. Journal of Global Oncology. 1-9. PMID 30422746 DOI: 10.1200/Jgo.18.00086  0.386
2018 Reid S, Newman AM, Diehn M, Alizadeh AA, Tibshirani R. Genomic Feature Selection by Coverage Design Optimization. Journal of Applied Statistics. 45: 2658-2676. PMID 30294060 DOI: 10.1080/02664763.2018.1432577  0.534
2018 Harris JP, Nwachukwu C, Qian Y, Pollom E, Loo BW, Das M, Diehn M. Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 124: 76-85. PMID 30268484 DOI: 10.1016/J.Lungcan.2018.07.033  0.427
2018 Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Levy R, ... ... Diehn M, et al. Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018785246. PMID 30125215 DOI: 10.1200/Jco.2018.78.5246  0.56
2018 Qian Y, Von Eyben R, Liu Y, Chin FT, Miao Z, Apte S, Carter JN, Binkley MS, Pollom EL, Harris JP, Prionas ND, Kissel M, Simmons A, Diehn M, Shultz DB, et al. F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 29859786 DOI: 10.1016/J.Ijrobp.2018.03.045  0.32
2018 Zhang W, Bouchard G, Yu A, Shafiq M, Jamali M, Shrager JB, Ayers K, Bakr S, Gentles AJ, Diehn M, Quon A, West RB, Nair V, van de Rijn M, Napel S, et al. GFPT2-expressing cancer-associated fibroblasts mediate metabolic reprogramming in human lung adenocarcinoma. Cancer Research. PMID 29760045 DOI: 10.1158/0008-5472.Can-17-2928  0.389
2018 Moding EJ, Diehn M, Wakelee HA. Circulating tumor DNA testing in advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 119: 42-47. PMID 29656751 DOI: 10.1016/J.Lungcan.2018.02.019  0.469
2018 Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, Tsimberidou AM, Vasalos P, Billman BL, Oliver TK, Bruinooge SS, et al. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017768671. PMID 29504847 DOI: 10.1200/Jco.2017.76.8671  0.364
2018 Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, Tsimberidou AM, Vasalos P, Billman BL, Oliver TK, Bruinooge SS, et al. Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. Archives of Pathology & Laboratory Medicine. PMID 29504834 DOI: 10.5858/Arpa.2018-0901-Sa  0.334
2018 Przybyl J, Chabon JJ, Spans L, Ganjoo K, Vennam S, Newman AM, Forgó E, Varma S, Zhu S, Debiec-Rychter M, Alizadeh AA, Diehn M, van de Rijn M. Combination approach for detecting different types of alterations in circulating tumor DNA in leiomyosarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29463554 DOI: 10.1158/1078-0432.Ccr-17-3704  0.578
2018 Lee J, Li B, Cui Y, Sun X, Wu J, Zhu H, Yu J, Gensheimer MF, Loo BW, Diehn M, Li R. A Quantitative CT Imaging Signature Predicts Survival and Complements Established Prognosticators in Stage I Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 29439884 DOI: 10.1016/J.Ijrobp.2018.01.006  0.367
2018 Soo J, Schroers-Martin J, Garofalo A, Kurtz DM, D'Emilio N, Grimm DR, Luikart H, Diehn M, Sunwoo JB, Khush KK, Alizadeh AA. Post-transplant head and neck cancers: A prospective analysis of clinical factors for risk stratification. Journal of Clinical Oncology. 36: e18051-e18051. DOI: 10.1200/Jco.2018.36.15_Suppl.E18051  0.474
2018 Soo J, Schroers-Martin J, Garofalo A, Kurtz DM, D'Emilio N, Grimm DR, Luikart H, Van De Rijn M, Diehn M, Khush KK, Alizadeh AA. Early detection of post-transplant lymphoproliferative disorder using circulating tumor DNA. Journal of Clinical Oncology. 36: 7572-7572. DOI: 10.1200/Jco.2018.36.15_Suppl.7572  0.491
2018 Schroers-Martin JG, Garofalo A, Soo J, Jin MC, Kurtz DM, Buedts L, Dührsen U, Hüttmann A, Cottereau AS, Meignan M, Casasnovas O, Westin JR, Gaidano G, Rossi D, Roschewski M, ... ... Diehn M, et al. Lymphoma Virome Dynamics Revealed By Cell-Free DNA Sequencing Blood. 132: 2861-2861. DOI: 10.1182/Blood-2018-99-119905  0.542
2018 Mehrmohamadi M, Esfahani MS, Soo J, Scherer F, Schroers-Martin JG, Chen B, Kurtz DM, Hamilton E, Liu CL, Diehn M, Alizadeh AA. Distinct Chromatin Accessibility Profiles of Lymphoma Subtypes Revealed By Targeted Cell Free DNA Profiling Blood. 132: 672-672. DOI: 10.1182/Blood-2018-99-119361  0.57
2018 Jin MC, Schroers-Martin JG, Kurtz DM, Buedts L, Esfahani MS, Macaulay C, Sworder B, Soo J, Glover C, Roschewski M, Wilson WH, Dührsen U, Hüttmann A, Rossi D, Gaidano G, ... ... Diehn M, et al. Noninvasive Genotyping and Monitoring of Classical Hodgkin Lymphoma Blood. 132: 2838-2838. DOI: 10.1182/Blood-2018-99-119140  0.578
2018 Przybyl J, Chabon JJ, Spans L, Ganjoo K, Vennam S, Newman AM, Forgó E, Varma S, Zhu S, Debiec-Rychter M, Alizadeh A, Diehn M, Rijn Mvd. Abstract A05: Circulating tumor DNA levels correlate with response to treatment in LMS patients Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Sarcomas17-A05  0.434
2018 Ross JB, Schueler E, Ko R, Bush K, Maxim PG, Gensheimer MF, Loo BW, Diehn M. Radiologic Quantification and Predictors of Lung Fibrosis after Stereotactic Ablative Radiation Therapy(SABR) International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1890  0.322
2018 Ko R, Abelson J, Kothary N, Fleischmann D, Hofmann L, Hovsepian D, Louie J, Hwang G, Sze D, Kielar K, Maxim P, Le Q, Diehn M, Loo B. Pulmonary Interstitial Lymphography and Patterns of Recurrence after Stereotactic Ablative Radiation Therapy(SABR) of Lung Tumors International Journal of Radiation Oncology*Biology*Physics. 102: e689. DOI: 10.1016/J.Ijrobp.2018.07.1856  0.368
2018 Chen E, Chaudhuri A, Nabet B, Chabon J, Merriott D, Loo B, Alizadeh A, Diehn M. Analysis of Circulating Tumor DNA Kinetics during Stereotactic Ablative Radiation Therapy for Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e676. DOI: 10.1016/J.Ijrobp.2018.07.1826  0.615
2018 Binkley M, Koenig J, Sodji Q, Maxim P, Diehn M, Loo B, Gensheimer M. Predicting Per-Lesion Local Recurrence in Locally Advanced Lung Cancer using Metabolic Tumor Volume on Pre- and Mid-Radiation FDG-PET International Journal of Radiation Oncology*Biology*Physics. 102: e674. DOI: 10.1016/J.Ijrobp.2018.07.1820  0.362
2018 Quaovi S, Ko R, Bush K, Binkley MS, Pickthorn W, Maxim PG, Gensheimer MF, Diehn M, Loo BW. Esophagitis in Patients Treated with Thoracic Stereotactic Ablative Radiation Therapy (SABR) to Tumors within 2 cm of the Esophagus International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1802  0.352
2018 Chaudhuri AA, Nabet BY, Merriott DJ, Jin M, Chen EL, Chabon JJ, Newman AM, Stehr H, Say C, Carter JN, Walters S, Becker H, Das M, Padda SK, Loo BW, ... ... Diehn M, et al. (OA02) Circulating Tumor DNA Quantitation for Early Response Assessment of Immune Checkpoint Inhibitors for Metastatic Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 101: e1-e2. DOI: 10.1016/J.Ijrobp.2018.02.041  0.599
2017 Blakely CM, Watkins TBK, Wu W, Gini B, Chabon JJ, McCoach CE, McGranahan N, Wilson GA, Birkbak NJ, Olivas VR, Rotow J, Maynard A, Wang V, Gubens MA, Banks KC, ... ... Diehn M, et al. Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers. Nature Genetics. PMID 29106415 DOI: 10.1038/Ng.3990  0.425
2017 Aalipour A, Dudley JC, Park SM, Murty S, Chabon JJ, Boyle EA, Diehn M, Gambhir SS. Deactivated CRISPR Associated Protein 9 for Minor-Allele Enrichment in Cell-Free DNA. Clinical Chemistry. PMID 29038154 DOI: 10.1373/Clinchem.2017.278911  0.338
2017 Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Khodadoust MS, Esfahani MS, Liu CL, Zhou L, Scherer F, Kurtz DM, Say C, Carter JN, Merriott DJ, ... ... Diehn M, et al. Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discovery. PMID 28899864 DOI: 10.1158/2159-8290.Cd-17-0716  0.613
2017 Gensheimer MF, Hong JC, Chang-Halpenny C, Zhu H, Eclov NCW, To J, Murphy JD, Wakelee HA, Neal JW, Le QT, Hara WY, Quon A, Maxim PG, Graves EE, Olson MR, ... Diehn M, et al. Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28830717 DOI: 10.1016/J.Radonc.2017.08.007  0.372
2017 Lee J, Cui Y, Sun X, Li B, Wu J, Li D, Gensheimer MF, Loo BW, Diehn M, Li R. Prognostic value and molecular correlates of a CT image-based quantitative pleural contact index in early stage NSCLC. European Radiology. PMID 28786009 DOI: 10.1007/S00330-017-4996-4  0.326
2017 Li B, Cui Y, Diehn M, Li R. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer. Jama Oncology. PMID 28687838 DOI: 10.1001/Jamaoncol.2017.1609  0.388
2017 Newman AM, Gentles AJ, Liu CL, Diehn M, Alizadeh AA. Data normalization considerations for digital tumor dissection. Genome Biology. 18: 128. PMID 28679399 DOI: 10.1186/S13059-017-1257-4  0.565
2017 Qian Y, Zhu H, Pollom EL, Durkee BY, Chaudhuri AA, Gensheimer MF, Diehn M, Shultz DB, Loo BW. Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors. Practical Radiation Oncology. PMID 28669706 DOI: 10.1016/J.Prro.2017.04.005  0.362
2017 Radwan N, Phillips R, Ross A, Rowe SP, Gorin MA, Antonarakis ES, Deville C, Greco S, Denmeade S, Paller C, Song DY, Diehn M, Wang H, Carducci M, Pienta KJ, et al. A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE). Bmc Cancer. 17: 453. PMID 28662647 DOI: 10.1186/s12885-017-3455-6  0.345
2017 Edelman MJ, Hu C, Le QT, Donington JS, D'Souza WD, Dicker AP, Loo BW, Gore EM, Videtic GMM, Evans NR, Leach JW, Diehn M, Feigenberg SJ, Chen Y, Paulus R, et al. Randomized Phase II Study of Preoperative Chemoradiotherapy +/- Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-small Cell Lung Cancer: NRG Oncology RTOG 0839. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28629896 DOI: 10.1016/J.Jtho.2017.06.007  0.364
2017 Harris JP, Patel MI, Loo BW, Wakelee HA, Diehn M. A population-based comparative effectiveness study of chemoradiation regimens and sequences in stage III non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 108: 173-182. PMID 28625632 DOI: 10.1016/J.Lungcan.2017.03.017  0.376
2017 Scherer F, Kurtz DM, Diehn M, Alizadeh AA. High-throughput sequencing for noninvasive disease detection in hematologic malignancies. Blood. PMID 28600337 DOI: 10.1182/Blood-2017-03-735639  0.576
2017 Binkley MS, King MT, Shrager JB, Bush K, Chaudhuri AA, Popat R, Gensheimer MF, Maxim PG, Henry Guo H, Diehn M, Nair VS, Loo BW. Pulmonary function after lung tumor stereotactic ablative radiotherapy depends on regional ventilation within irradiated lung. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 28460826 DOI: 10.1016/J.Radonc.2017.03.021  0.351
2017 Offin M, Chabon JJ, Razavi P, Isbell JM, Rudin CM, Diehn M, Li BT. Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA. Journal of Oncology. 2017: 4517834. PMID 28392802 DOI: 10.1155/2017/4517834  0.446
2017 Chuang JC, Stehr H, Liang Y, Das M, Huang J, Diehn M, Wakelee HA, Neal JW. ERBB2-mutated metastatic non-small cell lung cancer: response and resistance to targeted therapies. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 28167203 DOI: 10.1016/J.Jtho.2017.01.023  0.399
2017 Chaudhuri A, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Carter JN, Merriott DJ, Liu CL, Kurtz DM, Dudley JC, Padda SK, Shrager JB, Neal JW, Wakelee HA, ... ... Diehn M, et al. Analysis of circulating tumor DNA in localized lung cancer for detection of molecular residual disease and personalization of adjuvant strategies. Journal of Clinical Oncology. 35: 8519-8519. DOI: 10.1200/Jco.2017.35.15_Suppl.8519  0.614
2017 Soo J, Kurtz DM, Scherer F, Craig AF, Jin MC, Westin JR, Rossi D, Gaidano G, Advani RH, Diehn M, Alizadeh AA. Elucidation of distinct mutational patterns between diffuse large B cell lymphoma subtypes utilizing circulating tumor DNA. Journal of Clinical Oncology. 35: 7538-7538. DOI: 10.1200/Jco.2017.35.15_Suppl.7538  0.544
2017 Jin MC, Kurtz DM, Esfahani MS, Scherer F, Craig AF, Soo J, Khodadoust MS, Saganty RS, Chabon JJ, Schroers-Martin J, Stehr H, Advani RH, Rossi D, Gaidano G, Westin JR, ... Diehn M, et al. Noninvasive detection of clinically relevant copy number alterations in diffuse large B-cell lymphoma. Journal of Clinical Oncology. 35: 7507-7507. DOI: 10.1200/Jco.2017.35.15_Suppl.7507  0.517
2017 Azad TD, Chaudhuri A, Newman AM, Stehr H, Schroers-Martin J, Chabon JJ, Fang P, Qiao Y, Liao ZX, Komaki R, Alizadeh AA, Lin SH, Diehn M. Circulating tumor DNA analysis for outcome prediction in localized esophageal cancer. Journal of Clinical Oncology. 35: 4055-4055. DOI: 10.1200/Jco.2017.35.15_Suppl.4055  0.564
2017 Diehn M, Alizadeh AA, Adams H, Lee JJ, Klassen S, Palma JF, Hinzman B, Lovejoy AF, Newman AM, Yao L, Yaung S, Balasubramanyam A, Rohr UP, Rosenthal A, Kube R, et al. Early prediction of clinical outcomes in resected stage II and III colorectal cancer (CRC) through deep sequencing of circulating tumor DNA (ctDNA). Journal of Clinical Oncology. 35: 3591-3591. DOI: 10.1200/Jco.2017.35.15_Suppl.3591  0.529
2017 Kurtz DM, Scherer F, Jin M, Soo J, Craig A, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust M, Advani RH, Levy R, ... ... Diehn M, et al. Development of a Dynamic Model for Personalized Risk Assessment in Large B-Cell Lymphoma Blood. 130: 826-826. DOI: 10.1182/Blood.V130.Suppl_1.826.826  0.319
2017 Kurtz DM, Jin M, Soo J, Scherer F, Craig A, Chabon JJ, Schroers-Martin JG, Liu CL, Stehr H, Schmitz C, Duehrsen U, Hüttmann A, Cottereau AS, Meignan M, Casasnovas O, ... ... Diehn M, et al. Circulating Tumor DNA Is a Reliable Measure of Tumor Burden at Diagnosis of Diffuse Large B Cell Lymphoma: An International Reproducibility Study Blood. 130: 310-310. DOI: 10.1182/Blood.V130.Suppl_1.310.310  0.449
2017 Schroers-Martin JG, Scherer F, Soo J, Kurtz DM, Liu CL, Stehr H, Bru A, Natkunam Y, Diehn M, Nadel B, Roulland S, Alizadeh AA. Hierarchy in Somatic Mutations Detected in Circulating and Tissue-Resident Follicular Lymphoma Precursors before Clinical Diagnosis Blood. 130: 308-308. DOI: 10.1182/Blood.V130.Suppl_1.308.308  0.389
2017 Jin M, Kurtz DM, Esfahani MS, Soo J, Craig A, Scherer F, Stehr H, Schroers-Martin JG, Bangs CD, Cherry A, Natkunam Y, Roschewski M, Wilson WH, Duehrsen U, Hüttmann A, ... ... Diehn M, et al. Clinical Impact of Somatic Copy Number Alterations in Circulating Tumor DNA from Diverse Lymphoma Subtypes Blood. 130: 2747-2747. DOI: 10.1182/Blood.V130.Suppl_1.2747.2747  0.4
2017 Gentles AJ, Hui A, Feng W, Nair RV, Yu A, Shafiq M, Forgo E, Khuong A, Xu Y, Hoang CD, West RB, Rijn Mvd, Diehn M, Plevritis SK. Abstract LB-219: Higher levels of mast cells associate with favorable outcomes in non-small cell lung cancer and correlate with lower malignant cell proliferation Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-219  0.421
2017 Zhang W, Bouchard G, Yu A, Shafiq M, Jamali M, Shrager J, Ayers K, Nair VS, Gentles A, Diehn M, Quon A, Napel S, Plevritis S. Abstract 4403: FDG uptake in human lung adenocarcinoma associated with invasion through the hexosamine biosynthesis pathway Cancer Research. 77: 4403-4403. DOI: 10.1158/1538-7445.Am2017-4403  0.3
2017 Jeong Y, Hoang N, Stehr H, Lovejoy A, Gentles A, Chaudhuri A, Loo B, Alizadeh A, Diehn M. Abstract 1034: Role of KEAP1/NRF2 and TP53 mutations in lung squamous cell carcinoma development and radiation resistance Cancer Research. 77: 1034-1034. DOI: 10.1158/1538-7445.Am2017-1034  0.423
2017 Chabon J, Chaudhuri A, Azad T, Kurtz D, Stehr H, Liu C, Martin JS, Merriott D, Carter J, Ayers K, Mansfield A, Jen J, Ren H, West R, Nair V, ... ... Diehn M, et al. MA 13.01 Clinical and Pathological Variables Influencing Noninvasive Detection of Early Stage Lung Cancer Using Circulating Tumor DNA Journal of Thoracic Oncology. 12: S1851. DOI: 10.1016/J.Jtho.2017.09.560  0.537
2017 Chaudhuri A, Lovejoy A, Chabon J, Newman A, Stehr H, Say C, Carter J, Zhou L, West R, Shrager J, Neal J, Wakelee H, Loo B, Alizadeh A, Diehn M. MA17.07 Circulating Tumor DNA Detects Minimal Residual Disease and Predicts Outcome in Localized Lung Cancer Journal of Thoracic Oncology. 12: S445. DOI: 10.1016/J.Jtho.2016.11.520  0.593
2017 Chaudhuri A, Chabon J, Lovejoy A, Newman A, Stehr H, Azad T, Carter J, Merriott D, Liu C, Kurtz D, Gensheimer M, Shrager J, Wakelee H, Neal J, Loo B, ... ... Diehn M, et al. Comparison of Circulating Tumor DNA Analysis and Surveillance Imaging After Treatment for Localized Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 99: S114. DOI: 10.1016/J.Ijrobp.2017.06.269  0.59
2017 Azad T, Chaudhuri A, Newman A, Stehr H, Schroers-Martin J, Chabon J, Fang P, Qiao Y, Liao Z, Komaki R, Alizadeh A, Lin S, Diehn M. Pretreatment Circulating Tumor DNA for Risk Stratification of Locally Advanced Esophageal Cancer Treated With Chemoradiation and Surgery International Journal of Radiation Oncology*Biology*Physics. 99: S90-S91. DOI: 10.1016/J.Ijrobp.2017.06.218  0.561
2017 Moding E, Maxim P, Diehn M, Loo B, Gensheimer M. Safety and Efficacy of Stereotactic Ablative Radiotherapy (SABR) to Multiple (3 or More) Lung Tumors International Journal of Radiation Oncology*Biology*Physics. 99: E482. DOI: 10.1016/J.Ijrobp.2017.06.1756  0.356
2017 Gensheimer MF, Hong JC, Chang-Halpenny CN, Eclov N, To J, Murphy JD, Wakelee HA, Neal JW, Le QT, Hara W, Quon A, Maxim PG, Graves EE, Olson MR, Diehn M, et al. Mid-radiation Therapy PET/CT for Prognostication and Detection of Early Progression in Patients With Stage III Non–small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1695  0.373
2017 Harris J, Nwachukwu C, Loo B, Das M, Diehn M. Patterns of Care and Health Disparities for Patients With Stage I Non–small Cell Lung Cancer in the US International Journal of Radiation Oncology*Biology*Physics. 99: E399. DOI: 10.1016/J.Ijrobp.2017.06.1556  0.327
2017 Merriott D, Chaudhuri A, Jin M, Chabon J, Newman A, Stehr H, Say C, Carter J, Walters S, Becker H, Das M, Padda S, Loo B, Wakelee H, Neal J, ... ... Diehn M, et al. Circulating Tumor DNA Quantitation for Early Response Assessment of Immune Checkpoint Inhibitors for Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 99: S20-S21. DOI: 10.1016/J.Ijrobp.2017.06.061  0.584
2017 Chaudhuri A, Lovejoy A, Chabon J, Newman A, Stehr H, Merriott D, Carter J, Azad T, Padda S, Gensheimer M, Wakelee H, Neal J, Loo B, Alizadeh A, Diehn M. Circulating Tumor DNA Analysis during Radiation Therapy for Localized Lung Cancer Predicts Treatment Outcome International Journal of Radiation Oncology*Biology*Physics. 99: S1-S2. DOI: 10.1016/J.Ijrobp.2017.06.021  0.6
2017 Anderson EM, Sharma A, Westover KD, Timmerman R, von Eyben R, Gensheimer MF, Maxim P, Loo BW, Diehn M, Shultz DB. (P084) Stereotactic Ablative Radiotherapy for Stage I Non-Small-Cell Lung Cancer Tumors Greater Than 5 cm International Journal of Radiation Oncology*Biology*Physics. 98: E38. DOI: 10.1016/J.Ijrobp.2017.02.180  0.418
2017 Chaudhuri AA, Chabon JJ, Lovejoy AF, Newman AM, Stehr H, Azad TD, Zhou L, Liu CL, Scherer F, Kurtz DM, Esfahani MS, Say C, Carter JN, Merriott D, Dudley J, ... ... Diehn M, et al. S012) Circulating Tumor DNA Detects Residual Disease and Anticipates Tumor Progression Earlier Than CT Imaging International Journal of Radiation Oncology Biology Physics. 98. DOI: 10.1016/J.Ijrobp.2017.02.048  0.368
2017 Wang S, Zhang B, Wakelee H, Diehn M, Kunder C, Neal J. Case Series of MET Exon 14 Skipping Mutation-positive Non–Small Cell Lung Cancers and Response to Crizotinib International Journal of Radiation Oncology*Biology*Physics. 98: 239. DOI: 10.1016/J.Ijrobp.2017.01.170  0.35
2016 Wu J, Gensheimer M, Dong X, Rubin D, Napel S, Diehn M, Loo B, Li R. SU-D-207B-05: Robust Intra-Tumor Partitioning to Identify High-Risk Subregions for Prognosis in Lung Cancer. Medical Physics. 43: 3349. PMID 28046308 DOI: 10.1118/1.4955673  0.387
2016 Aguilera TA, Rafat M, Castellini L, Shehade H, Kariolis MS, Hui AB, Stehr H, von Eyben R, Jiang D, Ellies LG, Koong AC, Diehn M, Rankin EB, Graves EE, Giaccia AJ. Reprogramming the immunological microenvironment through radiation and targeting Axl. Nature Communications. 7: 13898. PMID 28008921 DOI: 10.1038/Ncomms13898  0.324
2016 Wang SX, Zhang BM, Wakelee H, Diehn M, Kunder CA, Neal JW. PS01.67: Case Series of MET Exon 14 Skipping Mutation-Positive Non-Small Cell Lung Cancers and Response to Crizotinib: Topic: Medical Oncology. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 11: S312-S313. PMID 27969534 DOI: 10.1016/J.Jtho.2016.09.102  0.344
2016 Park SM, Wong DJ, Ooi CC, Kurtz DM, Vermesh O, Aalipour A, Suh S, Pian KL, Chabon JJ, Lee SH, Jamali M, Say C, Carter JN, Lee LP, Kuschner WG, ... ... Diehn M, et al. Molecular profiling of single circulating tumor cells from lung cancer patients. Proceedings of the National Academy of Sciences of the United States of America. PMID 27956614 DOI: 10.1073/Pnas.1608461113  0.47
2016 Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Thomas Purcell W, Ross Camidge D, ... ... Diehn M, et al. Corrigendum: Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nature Communications. 7: 13513. PMID 27841271 DOI: 10.1038/Ncomms13513  0.557
2016 Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Visser BC, Poultsides GA, Advani RH, ... ... Diehn M, et al. Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA. Science Translational Medicine. 8: 364ra155. PMID 27831904 DOI: 10.1126/Scitranslmed.Aai8545  0.611
2016 Chaudhuri AA, Lovejoy AF, Chabon JJ, Newman A, Stehr H, Say C, Aggarwal S, Carter JN, West RB, Neal JW, Wakelee HA, Loo BW, Alizadeh A, Diehn M. CAPP-Seq Circulating Tumor DNA Analysis for Early Detection of Tumor Progression After Definitive Radiation Therapy for Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: S41-S42. PMID 27675925 DOI: 10.1016/J.Ijrobp.2016.06.112  0.617
2016 Waliany S, Shultz DB, Gensheimer MF, Loo BW, Diehn M. Role of Surveillance Imaging Versus Symptoms and Signs in Detection of Recurrence of Non-Small Cell Lung Cancer After Curative Intent Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: S155. PMID 27675661 DOI: 10.1016/J.Ijrobp.2016.06.375  0.36
2016 Wu J, Gensheimer MF, Dong X, Rubin DL, Napel S, Diehn M, Loo BW, Li R. Intratumor Partitioning of Serial Computed Tomography and FDG Positron Emission Tomography Images Identifies High-Risk Tumor Subregions and Predicts Patterns of Failure in Non-Small Cell Lung Cancer After Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: S100. PMID 27675525 DOI: 10.1016/J.Ijrobp.2016.06.249  0.384
2016 Anderson E, Filippi AR, Badellino S, Ricardi U, von Eyben R, Gensheimer MF, Diehn M, Loo BW, Shultz DB. Imaging Features Associated With Disease Progression After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Multi-Institutional Pooled Analysis. International Journal of Radiation Oncology, Biology, Physics. 96: E485-E486. PMID 27674817 DOI: 10.1016/J.Ijrobp.2016.06.1848  0.38
2016 Shaffer J, Negahdar M, von Eyben R, Diehn M, Maxim PG, Loo BW. Four-Dimensional Computed Tomography Pulmonary Nodule Elastometry as a Predictor of Regional Recurrence Following Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E460. PMID 27674752 DOI: 10.1016/J.Ijrobp.2016.06.1785  0.369
2016 Prionas ND, Aggarwal S, Shaffer J, von Eyben R, Graves EE, Maxim PG, Quon A, Gensheimer MF, Diehn M, Loo BW. Temporal Change in Quantitative Positron Emission Tomography Metrics Predicts Recurrence in Early-Stage Lung Cancer Patients Treated With Stereotactic Ablative Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: E457. PMID 27674743 DOI: 10.1016/J.Ijrobp.2016.06.1777  0.357
2016 Binkley MS, King M, Bush K, Shrager JB, Chaudhuri AA, Popat R, Maxim PG, Guo HH, Diehn M, Nair VS, Loo BW. Regional Ventilation Predicts Change in Pulmonary Function After Stereotactic Ablative Radiation Therapy of Lung Tumors. International Journal of Radiation Oncology, Biology, Physics. 96: E456-E457. PMID 27674740 DOI: 10.1016/J.Ijrobp.2016.06.1776  0.361
2016 Qian Y, Pollom E, Durkee BY, von Eyben R, Gensheimer MF, Shultz DB, Diehn M, Loo BW. Patterns of Failure After Hypofractionated Intensity Modulated Radiation Therapy for Patients With Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: E422-E423. PMID 27674651 DOI: 10.1016/J.Ijrobp.2016.06.1692  0.373
2016 Carter JN, Aggarwal S, Radish K, Allen JR, Koong AC, Chang DT, Loo BW, Diehn M, Kunz PL, Gensheimer MF. Effectiveness of Radiation Therapy for Low- to Intermediate-Grade Neuroendocrine Tumors. International Journal of Radiation Oncology, Biology, Physics. 96: E202-E203. PMID 27674052 DOI: 10.1016/J.Ijrobp.2016.06.1100  0.343
2016 Jeong Y, Hoang NT, Lovejoy A, Stehr H, Newman AM, Gentles AJ, Kong W, Truong D, Martin S, Chaudhuri A, Heiser D, Zhou L, Say C, Carter JN, Hiniker SM, ... ... Diehn M, et al. Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance. Cancer Discovery. PMID 27663899 DOI: 10.1158/2159-8290.Cd-16-0127  0.598
2016 Cirujeda P, Cid Y, Muller H, Rubin D, Aguilera T, Loo B, Diehn M, Binefa X, Depeursinge A. A 3-D Riesz-Covariance Texture Model for Prediction of Nodule Recurrence in Lung CT. Ieee Transactions On Medical Imaging. PMID 27429433 DOI: 10.1109/Tmi.2016.2591921  0.335
2016 Pollom EL, Qian Y, Durkee BY, von Eyben R, Maxim PG, Shultz DB, Gensheimer M, Diehn M, Loo BW. Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer. Clinical Lung Cancer. PMID 27378172 DOI: 10.1016/J.Cllc.2016.05.024  0.385
2016 Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Purcell WT, Camidge DR, ... ... Diehn M, et al. Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nature Communications. 7: 11815. PMID 27283993 DOI: 10.1038/Ncomms11815  0.54
2016 Chaudhuri AA, Binkley MS, Rigdon J, Carter JN, Aggarwal S, Dudley SA, Qian Y, Kumar KA, Hara WY, Gensheimer M, Nair VS, Maxim PG, Shultz DB, Bush K, Trakul N, ... ... Diehn M, et al. Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR). Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27267049 DOI: 10.1016/J.Radonc.2016.05.007  0.326
2016 Wu J, Gensheimer MF, Dong X, Rubin DL, Napel S, Diehn M, Loo BW, Li R. Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study. International Journal of Radiation Oncology, Biology, Physics. PMID 27212196 DOI: 10.1016/J.Ijrobp.2016.03.018  0.343
2016 Wu J, Aguilera T, Shultz D, Gudur M, Rubin DL, Loo BW, Diehn M, Li R. Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis. Radiology. 151829. PMID 27046074 DOI: 10.1148/Radiol.2016151829  0.368
2016 Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C, Zhou L, Carter JN, West RB, Sledge GW, Shrager JB, ... ... Diehn M, et al. Integrated digital error suppression for improved detection of circulating tumor DNA. Nature Biotechnology. PMID 27018799 DOI: 10.1038/Nbt.3520  0.605
2016 Binkley MS, Shrager JB, Chaudhuri A, Popat R, Maxim PG, Shultz DB, Diehn M, Loo BW. Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors. Radiation Oncology (London, England). 11: 40. PMID 26975700 DOI: 10.1186/S13014-016-0616-8  0.359
2016 Newman AM, Lovejoy AF, Klass DM, Kurtz DM, Chabon JJ, Scherer F, Stehr H, Liu CL, Bratman SV, Say C, Zhou L, Carter JN, West RB, Sledge GW, Shrager JB, ... ... Diehn M, et al. Integrated digital error suppression for noninvasive detection of circulating tumor DNA in NSCLC. Journal of Clinical Oncology. 34: e20500-e20500. DOI: 10.1200/Jco.2016.34.15_Suppl.E20500  0.575
2016 Chabon JJ, Simmons A, Newman AM, Lovejoy AF, Esfahani MS, Haringsma H, Kurtz DM, Stehr H, Scherer F, Durkin KA, Otterson GA, Purcell WT, Camidge DR, Goldman JW, Sequist LV, ... ... Diehn M, et al. Inter- and intra-patient heterogeneity of resistance mechanisms to the mutant EGFR selective inhibitor rociletinib. Journal of Clinical Oncology. 34: 9000-9000. DOI: 10.1200/Jco.2016.34.15_Suppl.9000  0.523
2016 Edelman MJ, Hu C, Le Q, Donington J, D'Souza WD, Dicker A, Loo BW, Gore E, Videtic GM, Evans NR, Leach J, Diehn M, Feigenberg SJ, Chen Y, Bradley JD. Randomized phase II study of preoperative chemoradiotherapy (CRT)+/- Panitumumab (P) followed by consolidation chemotherapy (C) in potentially operable locally advanced (stage IIIa, N2+) non-small cell lung cancer (LANSCLC): Nrg oncology/RTOG 0839. Journal of Clinical Oncology. 34: 8510-8510. DOI: 10.1200/Jco.2016.34.15_Suppl.8510  0.349
2016 Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Advani RH, Maeda LS, Gupta NK, ... ... Diehn M, et al. Noninvasive molecular subtyping and risk stratification of DLBCL. Journal of Clinical Oncology. 34: 7554-7554. DOI: 10.1200/Jco.2016.34.15_Suppl.7554  0.533
2016 Kurtz DM, Scherer F, Newman AM, Craig AF, Khodadoust MS, Lovejoy AF, Klass DM, Chabon JJ, Glover C, Zhou L, Liu CL, Gupta NK, Maeda LS, Advani RH, Levy R, ... Diehn M, et al. Prediction of therapeutic outcomes in DLBCL from circulating tumor DNA dynamics. Journal of Clinical Oncology. 34: 7511-7511. DOI: 10.1200/Jco.2016.34.15_Suppl.7511  0.553
2016 Jan M, Scherer F, Kurtz DM, Newman AM, Stehr H, Liu CL, Zhou L, Glover C, Advani RH, Maeda LS, Gupta NK, Levy R, Kunder CA, Sánchez-García I, Diehn M, et al. Absence of Evidence Implicating Hematopoietic Stem Cells As Common Progenitors for DLBCL Mutations Blood. 128: 4107-4107. DOI: 10.1182/Blood.V128.22.4107.4107  0.58
2016 Kurtz DM, Scherer F, Newman AM, Craig A, Jin M, Stehr H, Chabon JJ, Esfahani M, Liu CL, Zhou L, Glover C, Visser BC, Poultsides G, Advani RH, Maeda LS, ... ... Diehn M, et al. Noninvasive Detection of BCL2, BCL6, and MYC Translocations in Diffuse Large B-Cell Lymphoma Blood. 128: 2930-2930. DOI: 10.1182/Blood.V128.22.2930.2930  0.602
2016 Scherer F, Kurtz DM, Newman AM, Craig A, Stehr H, Zhou L, Glover C, Kohrt H, Levy R, Diehn M, Alizadeh AA. Noninvasive Detection of Ibrutinib Resistance in Non-Hodgkin Lymphoma Using Cell-Free DNA Blood. 128: 1752-1752. DOI: 10.1182/Blood.V128.22.1752.1752  0.577
2016 Scherer F, Kurtz DM, Newman AM, Shahrokh Esfahani M, Craig A, Stehr H, Lovejoy AF, Chabon JJ, Liu CL, Zhou L, Glover C, Visser BC, Poultsides G, Advani RH, Maeda LS, ... ... Diehn M, et al. Development and Validation of Biopsy-Free Genotyping for Molecular Subtyping of Diffuse Large B-Cell Lymphoma Blood. 128: 1089-1089. DOI: 10.1182/Blood.V128.22.1089.1089  0.601
2016 Diehn M. Deep sequencing of circulating tumor DNA for personalized lung cancer detection and radiotherapy response monitoring Journal of Thoracic Oncology. 11: S3. DOI: 10.1016/J.Jtho.2015.12.003  0.467
2015 Myall NJ, Neal JW, Cho-Phan CD, Zhou LY, Stehr H, Zhou L, Diehn M, Wakelee HA. Long-Term Survival of a Patient With Non-Small-Cell Lung Cancer Harboring a V600E Mutation in the BRAF Oncogene. Clinical Lung Cancer. PMID 26776917 DOI: 10.1016/J.Cllc.2015.12.001  0.394
2015 Chaudhuri AA, Binkley MS, Osmundson EC, Alizadeh AA, Diehn M. Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA. Seminars in Radiation Oncology. 25: 305-12. PMID 26384278 DOI: 10.1016/J.Semradonc.2015.05.001  0.597
2015 Gentles AJ, Bratman SV, Lee LJ, Harris JP, Feng W, Nair RV, Shultz DB, Nair VS, Hoang CD, West RB, Plevritis SK, Alizadeh AA, Diehn M. Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer. Journal of the National Cancer Institute. 107. PMID 26286589 DOI: 10.1093/Jnci/Djv211  0.604
2015 Westover KD, Loo BW, Gerber DE, Iyengar P, Choy H, Diehn M, Hughes R, Schiller J, Dowell J, Wardak Z, Sher D, Christie A, Xie XJ, Corona I, Sharma A, et al. Precision Hypofractionated Radiation Therapy in Poor Performing Patients With Non-Small Cell Lung Cancer: Phase 1 Dose Escalation Trial. International Journal of Radiation Oncology, Biology, Physics. 93: 72-81. PMID 26279026 DOI: 10.1016/J.Ijrobp.2015.05.004  0.369
2015 Yu AS, von Eyben R, Yamamoto T, Diehn M, Shultz DB, Loo BW, Maxim PG. Anatomic optimization of lung tumor stereotactic ablative radiation therapy. Practical Radiation Oncology. PMID 26231596 DOI: 10.1016/J.Prro.2015.05.008  0.339
2015 Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK, Alizadeh AA. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nature Medicine. 21: 938-45. PMID 26193342 DOI: 10.1038/Nm.3909  0.612
2015 Binkley MS, Trakul N, Jacobs LR, von Eyben R, Le QT, Maxim PG, Loo BW, Shultz DB, Diehn M. Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 26025776 DOI: 10.1016/J.Ijrobp.2015.04.004  0.339
2015 Chaudhuri AA, Tang C, Binkley MS, Jin M, Wynne JF, von Eyben R, Hara WY, Trakul N, Loo BW, Diehn M. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. Lung Cancer (Amsterdam, Netherlands). 89: 50-6. PMID 25997421 DOI: 10.1016/J.Lungcan.2015.04.014  0.398
2015 Jeong Y, Swami S, Krishnan AV, Williams JD, Martin S, Horst RL, Albertelli MA, Feldman BJ, Feldman D, Diehn M. Inhibition of Mouse Breast Tumor Initiating Cells by Calcitriol and Dietary Vitamin D. Molecular Cancer Therapeutics. PMID 25934710 DOI: 10.1158/1535-7163.Mct-15-0066  0.323
2015 Kurtz DM, Green MR, Bratman SV, Scherer F, Liu CL, Kunder CA, Takahashi K, Glover C, Keane C, Kihira S, Visser B, Callahan J, Kong KA, Faham M, Corbelli KS, ... ... Diehn M, et al. Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood. 125: 3679-87. PMID 25887775 DOI: 10.1182/Blood-2015-03-635169  0.537
2015 Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nature Methods. 12: 453-7. PMID 25822800 DOI: 10.1038/Nmeth.3337  0.527
2015 Bratman SV, Newman AM, Alizadeh AA, Diehn M. Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq. Expert Review of Molecular Diagnostics. 15: 715-9. PMID 25773944 DOI: 10.1586/14737159.2015.1019476  0.601
2015 Shultz DB, Diehn M, Loo BW. To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer. Seminars in Radiation Oncology. 25: 78-86. PMID 25771411 DOI: 10.1016/J.Semradonc.2014.11.005  0.404
2015 Yom SS, Diehn M, Raben D. Molecular determinants of radiation response in non-small cell lung cancer. Seminars in Radiation Oncology. 25: 67-77. PMID 25771410 DOI: 10.1016/J.Semradonc.2014.12.007  0.415
2015 Harris JP, Chang-Halpenny CN, Maxim PG, Quon A, Graves EE, Diehn M, Loo BW. Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic Factors. Clinical Lung Cancer. PMID 25770888 DOI: 10.1016/J.Cllc.2015.01.007  0.384
2015 Kurtz DM, Scherer F, Green MR, Khodadoust MS, Klass DM, Zhou L, Krishnan R, Glover C, Liu CL, Kong KA, Faham M, Levy R, Diehn M, Alizadeh AA. Distinct early response dynamics of circulating tumor DNA and circulating tumor cells during therapy of B-cell NHL. Journal of Clinical Oncology. 33: 8570-8570. DOI: 10.1200/Jco.2015.33.15_Suppl.8570  0.589
2015 Scherer F, Kurtz DM, Green MR, Newman AM, Klass DM, Zhou L, Krishnan R, Liu CL, Glover C, Ohgami RS, Hicks RJ, Keane C, Kong KA, Faham M, Hertzberg MS, ... ... Diehn M, et al. Pre-treatment circulating tumor DNA as a biomarker for disease burden in diffuse large B cell lymphoma (DLBCL). Journal of Clinical Oncology. 33: 8539-8539. DOI: 10.1200/Jco.2015.33.15_Suppl.8539  0.597
2015 Kurtz DM, Scherer F, Newman AM, Lovejoy AF, Klass DM, Chabon JJ, Gambhir S, Diehn M, Alizadeh AA. Dynamic Noninvasive Genomic Monitoring for Outcome Prediction in Diffuse Large B-Cell Lymphoma Blood. 126: 130-130. DOI: 10.1182/Blood.V126.23.130.130  0.584
2015 Scherer F, Kurtz DM, Newman AM, Stehr H, Liu CL, Zhou L, Craig AF, Chabon JJ, Lovejoy AF, Klass DM, Glover C, Ohgami RS, Kunder CA, Visser BC, Poultsides G, ... ... Diehn M, et al. Noninvasive Genotyping and Assessment of Treatment Response in Diffuse Large B Cell Lymphoma Blood. 126: 114-114. DOI: 10.1182/Blood.V126.23.114.114  0.593
2015 Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Yue X, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK, Alizadeh AA. Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-Pr09  0.449
2015 Diehn M. Deep sequencing of circulating tumor DNA for personalized cancer detection and monitoring Annals of Oncology. 26: vii3. DOI: 10.1093/Annonc/Mdv398.02  0.391
2015 Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK, Alizadeh AA. The prognostic landscape of genes and infiltrating immune cells across human cancers Nature Medicine. 21: 938-945. DOI: 10.1038/nm.3909  0.563
2015 Chaudhuri A, Binkley M, Carter J, Aggarwal S, Maxim P, Shultz D, Diehn M, Guo H, Loo B. Pretreatment FDG Uptake of Non-Target Lung Tissue is Significantly Associated With Radiation Pneumonitis Following Stereotactic Ablative Radiation Therapy (SABR) International Journal of Radiation Oncology*Biology*Physics. 93: S150-S151. DOI: 10.1016/J.Ijrobp.2015.07.357  0.32
2015 Klass D, Newman A, Lovejoy A, Zhou L, Stehr H, Xu T, He J, Komaki R, Liao Z, Maru D, Alizadeh A, Lin S, Diehn M. Analysis of Circulating Tumor DNA in Esophageal Carcinoma Patients Treated With Chemoradiation Therapy International Journal of Radiation Oncology*Biology*Physics. 93: S104-S105. DOI: 10.1016/J.Ijrobp.2015.07.251  0.562
2015 Say C, Diehn M, Loo BW, Shultz DB. Regional Failure After Stereotactic Ablative Radiation Therapy for Early-Stage Lung Cancer International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1660  0.344
2015 Binkley M, Shrager J, Chaudhuri A, Popat R, Maxim P, Shultz D, Diehn M, Loo B. Time Course and Predictive Factors for Lung Volume Reduction Following Stereotactic Ablative Radiation Therapy (SABR) of Lung Tumors International Journal of Radiation Oncology*Biology*Physics. 93: E424. DOI: 10.1016/J.Ijrobp.2015.07.1628  0.376
2015 Wang A, Diehn M, Loo B, von Eyben R, Graves E, Shultz D, Bazan J. Preradiation Therapy Metabolic Tumor Growth Rate Predicts Survival and Progression in Patients With Non-Small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 93: E405. DOI: 10.1016/J.Ijrobp.2015.07.1580  0.416
2014 Kuo P, Bratman SV, Shultz DB, von Eyben R, Chan C, Wang Z, Say C, Gupta A, Loo BW, Giaccia AJ, Koong AC, Diehn M, Le QT. Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 5558-69. PMID 25189484 DOI: 10.1158/1078-0432.Ccr-14-1138  0.332
2014 Newman AM, Bratman SV, Stehr H, Lee LJ, Liu CL, Diehn M, Alizadeh AA. FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution. Bioinformatics (Oxford, England). 30: 3390-3. PMID 25143292 DOI: 10.1093/Bioinformatics/Btu549  0.531
2014 Xiao N, Lin Y, Cao H, Sirjani D, Giaccia AJ, Koong AC, Kong CS, Diehn M, Le QT. Neurotrophic factor GDNF promotes survival of salivary stem cells. The Journal of Clinical Investigation. 124: 3364-77. PMID 25036711 DOI: 10.1172/Jci74096  0.323
2014 Binkley MS, Shrager JB, Leung AN, Popat R, Trakul N, Atwood TF, Chaudhuri A, Maxim PG, Diehn M, Loo BW. Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema. International Journal of Radiation Oncology, Biology, Physics. 90: 216-23. PMID 25015205 DOI: 10.1016/J.Ijrobp.2014.05.025  0.375
2014 Moré JM, Eclov NC, Chung MP, Wynne JF, Shorter JH, Nelson DD, Hanlon AL, Burmeister R, Banos P, Maxim PG, Loo BW, Diehn M. Feasibility and potential utility of multicomponent exhaled breath analysis for predicting development of radiation pneumonitis after stereotactic ablative radiotherapy. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 957-64. PMID 24926543 DOI: 10.1097/Jto.0000000000000182  0.373
2014 Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, Shrager JB, Loo BW, Alizadeh AA, Diehn M. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nature Medicine. 20: 548-54. PMID 24705333 DOI: 10.1038/Nm.3519  0.637
2014 Shultz DB, Trakul N, Abelson JA, Murphy JD, Maxim PG, Le QT, Loo BW, Diehn M. Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer. Clinical Lung Cancer. 15: 294-301.e3. PMID 24594400 DOI: 10.1016/J.Cllc.2013.12.011  0.365
2014 Feng W, Gentles A, Nair RV, Huang M, Lin Y, Lee CY, Cai S, Scheeren FA, Kuo AH, Diehn M. Targeting unique metabolic properties of breast tumor initiating cells. Stem Cells (Dayton, Ohio). 32: 1734-45. PMID 24497069 DOI: 10.1002/Stem.1662  0.301
2014 Harris JP, Murphy JD, Hanlon AL, Le QT, Loo BW, Diehn M. A population-based comparative effectiveness study of radiation therapy techniques in stage III non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 88: 872-84. PMID 24495591 DOI: 10.1016/J.Ijrobp.2013.12.010  0.377
2014 Zhou B, Damrauer JS, Bailey ST, Hadzic T, Jeong Y, Clark K, Fan C, Murphy L, Lee CY, Troester MA, Miller CR, Jin J, Darr D, Perou CM, Levine RL, ... Diehn M, et al. Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal. The Journal of Clinical Investigation. 124: 553-63. PMID 24435044 DOI: 10.1172/Jci69804  0.336
2014 Lee CY, Lin Y, Bratman SV, Feng W, Kuo AH, Scheeren FA, Engreitz JM, Varma S, West RB, Diehn M. Neuregulin autocrine signaling promotes self-renewal of breast tumor-initiating cells by triggering HER2/HER3 activation. Cancer Research. 74: 341-52. PMID 24177178 DOI: 10.1158/0008-5472.Can-13-1055  0.351
2014 Kurtz DM, Green MR, Bratman SV, Liu C, Glover C, Keane C, Kong K, Faham M, Miklos DB, Advani RH, Levy R, Hertzberg MS, Gandhi MK, Diehn M, Alizadeh AA. Noninvasive monitoring of cellular versus acellular tumor DNA from immunoglobulin genes for DLBCL. Journal of Clinical Oncology. 32: 8504-8504. DOI: 10.1200/Jco.2014.32.15_Suppl.8504  0.547
2014 Chaudhuri AA, Tang C, Trakul N, Wynne J, Loo B, Diehn M. Abstract 864: Increased rates of radiation pneumonitis in patients receiving stereotactic ablative radiotherapy for central versus peripheral lung tumors Cancer Research. 74: 864-864. DOI: 10.1158/1538-7445.Am2014-864  0.414
2014 Kuo P, Bratman S, Shultz D, Eyben Rv, Chan C, Wang Z, Say C, Gupta A, Loo BW, Giaccia A, Koong A, Diehn M, Le Q. Abstract 848: Galectin-1 mediates radiation-related lymphopenia in non-small cell lung cancer and attenuates tumor radiation response Cancer Research. 74: 848-848. DOI: 10.1158/1538-7445.Am2014-848  0.444
2014 Diehn M, Bratman S, Newman A, Neal J, Wakelee H, Merritt R, Shrager J, Loo B, Alizadeh A. Ultrasensitive Detection of Circulating Tumor DNA in Non-Small Cell Lung Cancer by Deep Sequencing International Journal of Radiation Oncology*Biology*Physics. 90: S75. DOI: 10.1016/J.Ijrobp.2014.08.315  0.612
2014 Aguilera T, Trakul N, Shultz D, Maxim P, Diehn M, Loo B. Vertebral Fractures After Stereotactic Ablative Radiation Therapy of Lung Tumors International Journal of Radiation Oncology*Biology*Physics. 90: S160-S161. DOI: 10.1016/J.Ijrobp.2014.05.652  0.351
2014 Chaudhuri A, Tang C, Trakul N, Wynne J, Loo B, Diehn M. Increased Rates of Pneumonitis in Patients Receiving Stereotactic Ablative Radiation Therapy for Central Versus Peripheral Lung Tumors International Journal of Radiation Oncology*Biology*Physics. 90: S160. DOI: 10.1016/J.Ijrobp.2014.05.651  0.392
2014 Osmundson E, Newman A, Bratman S, Klass D, Zhou L, Pai J, Longacre T, Alizadeh A, Koong A, Diehn M. Circulating Tumor DNA as a Biomarker for Pancreatic Adenocarcinoma International Journal of Radiation Oncology*Biology*Physics. 90: S816-S817. DOI: 10.1016/J.Ijrobp.2014.05.2354  0.552
2014 Modlin L, Bratman S, Newman A, Eclov N, Neal J, Wakelee H, Shrager J, Loo B, Alizadeh A, Diehn M. Circulating Tumor DNA Concentrations Reflect Metabolic Tumor Volume in NSCLC International Journal of Radiation Oncology*Biology*Physics. 90: S812. DOI: 10.1016/J.Ijrobp.2014.05.2342  0.562
2014 Lee K, Loo B, Diehn M, Atwood T, Hristov D. Impact of Optimally-Gated PET on Tumor Localization and Quantification International Journal of Radiation Oncology*Biology*Physics. 90: S795. DOI: 10.1016/J.Ijrobp.2014.05.2296  0.302
2014 Negahdar M, Yamamoto T, Shultz D, Gable L, Shan X, Mittra E, Diehn M, Maxim P, Loo B. First in Human High-Resolution Imaging of Regional Lung Function by Single Energy Xenon CT Compared to Ventilation SPECT International Journal of Radiation Oncology*Biology*Physics. 90: S624. DOI: 10.1016/J.Ijrobp.2014.05.1858  0.32
2014 Harris J, Loo B, Diehn M. Factors Contributing to the Use of Intensity Modulated Versus 3D Conformal Radiation Therapy for Stage III Non-Small Cell Lung Cancer: A SEER-Medicare Study International Journal of Radiation Oncology*Biology*Physics. 90: S580. DOI: 10.1016/J.Ijrobp.2014.05.1746  0.357
2014 Li R, Aguilera T, Shultz D, Rubin D, Diehn M, Loo B. Improving The Prognostic Value Of FDG-PET For NSCLC Patients Treated With SABR Using Advanced Computational Modeling International Journal of Radiation Oncology*Biology*Physics. 90: S7. DOI: 10.1016/J.Ijrobp.2014.05.081  0.352
2013 Liu MB, Eclov NC, Trakul N, Murphy J, Diehn M, Le QT, Dieterich S, Maxim PG, Loo BW. Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors. Practical Radiation Oncology. 3: 294-300. PMID 24674401 DOI: 10.1016/J.Prro.2012.09.003  0.358
2013 Li R, Han B, Meng B, Maxim PG, Xing L, Koong AC, Diehn M, Loo BW. Clinical implementation of intrafraction cone beam computed tomography imaging during lung tumor stereotactic ablative radiation therapy. International Journal of Radiation Oncology, Biology, Physics. 87: 917-23. PMID 24113060 DOI: 10.1016/J.Ijrobp.2013.08.015  0.339
2013 Hong JC, Eclov NC, Yu Y, Rao AK, Dieterich S, Le QT, Diehn M, Sze DY, Loo BW, Kothary N, Maxim PG. Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy. Journal of Applied Clinical Medical Physics / American College of Medical Physics. 14: 4046. PMID 23470933 DOI: 10.1120/Jacmp.V14I2.4046  0.302
2013 Shultz DB, Grecula JC, Hayman J, Diehn M, Loo BW. The optimal use of radiotherapy in small cell lung cancer Jnccn Journal of the National Comprehensive Cancer Network. 11: 107-114. DOI: 10.6004/Jnccn.2013.0013  0.355
2013 Bratman S, Newman A, To J, Wynne J, Neal J, Wakelee H, Shrager J, Loo B, Alizadeh A, Diehn M. Noninvasive and Ultrasensitive Quantitation of Circulating Tumor DNA by Hybrid Capture and Deep Sequencing International Journal of Radiation Oncology*Biology*Physics. 87: S92. DOI: 10.1200/Jco.2014.32.15_Suppl.11016  0.625
2013 Green MR, Bratman S, Liu CL, Takahashi K, Glover C, Keane C, Kihira S, Kong K, Faham M, Karen C, Miklos DB, Advani RH, Levy R, Hertzberg MS, Frcpa, ... ... Diehn M, et al. Utility Of Non-Invasive Monitoring Of Circulating Tumor DNA At Diagnosis, Interim Therapy, and Relapse Of DLBCL Using High-Throughput Sequencing Of Immunoglobulin Genes Blood. 122: 4264-4264. DOI: 10.1182/Blood.V122.21.4264.4264  0.411
2013 Kadoya N, Kabus S, Lorenz C, Diehn M, Loo B, Keall P, Yamamoto T. TH-A-WAB-03: Radiation Dose Changes Pulmonary Function Measured by 4D-CT Ventilation Imaging Medical Physics. 40: 520-520. DOI: 10.1118/1.4815697  0.31
2013 Wynne J, Modlin L, Fan A, Tran T, Schwartz M, Loo B, Diehn M. Analysis of Circulating Tumor Cells in Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Ablative Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 87: S200-S201. DOI: 10.1016/J.Ijrobp.2013.06.517  0.445
2013 Li R, Han B, Meng B, Maxim P, Diehn M, Xing L, Koong A, Loo B. Clinical Implementation of Intrafraction CBCT Imaging During Lung Tumor SABR International Journal of Radiation Oncology*Biology*Physics. 87: S726. DOI: 10.1016/J.Ijrobp.2013.06.1923  0.364
2013 Bratman S, VanderVorst K, Feng W, Diehn M. Stromal Contributions to Radiation Resistance of Breast Cancer Stem Cells International Journal of Radiation Oncology*Biology*Physics. 87: S633. DOI: 10.1016/J.Ijrobp.2013.06.1673  0.363
2013 Aguilera T, Daniel G, Shultz D, Trakul N, Maxim P, Rubin D, Loo B, Diehn M. Novel Imaging Biomarkers in Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 87: S546. DOI: 10.1016/J.Ijrobp.2013.06.1444  0.385
2013 Harris J, Chang-Halpenny C, Maxim P, Quon A, Graves E, Diehn M, Loo B. Prognostic Metrics on Serial PET for Lung Tumors Treated With Hypofractionated Radiation International Journal of Radiation Oncology*Biology*Physics. 87: S511. DOI: 10.1016/J.Ijrobp.2013.06.1352  0.385
2013 Hiniker S, Modlin L, Harris J, Trakul N, Quon A, Maxim P, Graves E, Diehn M, Loo B. Performance of PET in Evaluating Local Recurrence After Stereotactic Ablative Radiation Therapy for Early Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 87: S11. DOI: 10.1016/J.Ijrobp.2013.06.034  0.353
2012 Abelson JA, Murphy JD, Trakul N, Bazan JG, Maxim PG, Graves EE, Quon A, Le QT, Diehn M, Loo BW. Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. Lung Cancer (Amsterdam, Netherlands). 78: 219-24. PMID 23009727 DOI: 10.1016/J.Lungcan.2012.08.016  0.344
2012 Trakul N, Harris JP, Le QT, Hara WY, Maxim PG, Loo BW, Diehn M. Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 1462-5. PMID 22895143 DOI: 10.1097/Jto.0B013E31825F22Ce  0.408
2012 Trakul N, Chang CN, Harris J, Chapman C, Rao A, Shen J, Quinlan-Davidson S, Filion EJ, Wakelee HA, Colevas AD, Whyte RI, Dieterich S, Maxim PG, Hristov D, Tran P, ... ... Diehn M, et al. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors. International Journal of Radiation Oncology, Biology, Physics. 84: 231-7. PMID 22381907 DOI: 10.1016/J.Ijrobp.2011.10.071  0.383
2012 Bratman S, Eclov N, Modlin L, Neal J, Loo B, Wu G, Richardson K, Newman A, Alizadeh A, Diehn M. Cell-free DNA as a Biomarker of Residual Disease Following Radiation Therapy for Non-small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S713. DOI: 10.1016/J.Ijrobp.2012.07.1908  0.532
2012 Trakul N, Murphy J, Loo B, Diehn M. Improved Outcomes in Stage I NSCLC Patients Treated in the Stereotactic Ablative Radiation Therapy Era: A Population-based Analysis International Journal of Radiation Oncology*Biology*Physics. 84: S608. DOI: 10.1016/J.Ijrobp.2012.07.1621  0.315
2012 Shultz D, Trakul N, Abelson J, Murphy J, Lee Q, Loo B, Diehn M. Anatomic and Metabolic Predictors of Failure After Stereotactic Ablative Radiation Therapy for Non-small Cell Lung Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S571-S572. DOI: 10.1016/J.Ijrobp.2012.07.1523  0.365
2011 Terezakis SA, Heron DE, Lavigne RF, Diehn M, Loo BW. What the diagnostic radiologist needs to know about radiation oncology. Radiology. 261: 30-44. PMID 21931140 DOI: 10.1148/Radiol.11101688  0.328
2011 Kozak MM, Murphy JD, Schipper ML, Donington JS, Zhou L, Whyte RI, Shrager JB, Hoang CD, Bazan J, Maxim PG, Graves EE, Diehn M, Hara WY, Quon A, Le QT, et al. Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 6: 920-6. PMID 21774104 DOI: 10.1097/Jto.0B013E31821517Db  0.395
2011 Liu MB, Eclov N, Trakul N, Diehn M, Maxim PG, Dieterich S, Loo BW. Ray-trace Calculation Significantly Overestimates Dose Compared To Monte Carlo Calculation In CyberKnife Stereotactic Ablative Radiotherapy Of Lung Tumors International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.1514  0.331
2010 Rothenberg ME, Clarke MF, Diehn M. The Myc connection: ES cells and cancer. Cell. 143: 184-6. PMID 20946977 DOI: 10.1016/J.Cell.2010.09.046  0.347
2010 Brown JM, Diehn M, Loo BW. Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer. International Journal of Radiation Oncology, Biology, Physics. 78: 323-7. PMID 20832663 DOI: 10.1016/J.Ijrobp.2010.04.070  0.354
2010 Diehn M, Majeti R. Metastatic cancer stem cells: an opportunity for improving cancer treatment? Cell Stem Cell. 6: 502-3. PMID 20569685 DOI: 10.1016/J.Stem.2010.05.001  0.319
2009 Chan KS, Espinosa I, Chao M, Wong D, Ailles L, Diehn M, Gill H, Presti J, Chang HY, van de Rijn M, Shortliffe L, Weissman IL. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 14016-21. PMID 19666525 DOI: 10.1073/Pnas.0906549106  0.455
2009 Diehn M, Cho RW, Clarke MF. Therapeutic implications of the cancer stem cell hypothesis. Seminars in Radiation Oncology. 19: 78-86. PMID 19249645 DOI: 10.1016/J.Semradonc.2008.11.002  0.325
2008 Diehn M, Nardini C, Wang DS, McGovern S, Jayaraman M, Liang Y, Aldape K, Cha S, Kuo MD. Identification of noninvasive imaging surrogates for brain tumor gene-expression modules. Proceedings of the National Academy of Sciences of the United States of America. 105: 5213-8. PMID 18362333 DOI: 10.1073/Pnas.0801279105  0.412
2008 Cho RW, Wang X, Diehn M, Shedden K, Chen GY, Sherlock G, Gurney A, Lewicki J, Clarke MF. Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells (Dayton, Ohio). 26: 364-71. PMID 17975224 DOI: 10.1634/Stemcells.2007-0440  0.383
2008 Liang Y, Diehn M, Bollen AW, Israel MA, Gupta N. Type I collagen is overexpressed in medulloblastoma as a component of tumor microenvironment. Journal of Neuro-Oncology. 86: 133-41. PMID 17653508 DOI: 10.1007/S11060-007-9457-5  0.321
2006 Diehn M, Clarke MF. Cancer stem cells and radiotherapy: new insights into tumor radioresistance. Journal of the National Cancer Institute. 98: 1755-7. PMID 17179471 DOI: 10.1093/Jnci/Djj505  0.395
2006 Palmer C, Diehn M, Alizadeh AA, Brown PO. Cell-type specific gene expression profiles of leukocytes in human peripheral blood. Bmc Genomics. 7: 115. PMID 16704732 DOI: 10.1186/1471-2164-7-115  0.709
2006 Diehn M, Bhattacharya R, Botstein D, Brown PO. Genome-scale identification of membrane-associated human mRNAs. Plos Genetics. 2: e11. PMID 16415983 DOI: 10.1371/Journal.Pgen.0020011  0.512
2005 Diehn JJ, Diehn M, Marmor MF, Brown PO. Differential gene expression in anatomical compartments of the human eye. Genome Biology. 6: R74. PMID 16168081 DOI: 10.1016/J.Ajo.2006.08.015  0.478
2005 Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, Lamborn KR, Berger MS, Botstein D, Brown PO, Israel MA. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proceedings of the National Academy of Sciences of the United States of America. 102: 5814-9. PMID 15827123 DOI: 10.1073/Pnas.0402870102  0.55
2005 Diehn M, Bhattacharya R, Botstein D, Brown P. Genome-scale Identification of Secreted and Membrane-associated Tumor Markers International Journal of Radiation Oncology*Biology*Physics. 63: S458. DOI: 10.1016/J.Ijrobp.2005.07.780  0.421
2004 Tu IP, Schaner M, Diehn M, Sikic BI, Brown PO, Botstein D, Fero MJ. A method for detecting and correcting feature misidentification on expression microarrays. Bmc Genomics. 5: 64. PMID 15357875 DOI: 10.1186/1471-2164-5-64  0.461
2004 Piedras-Rentería ES, Pyle JL, Diehn M, Glickfeld LL, Harata NC, Cao Y, Kavalali ET, Brown PO, Tsien RW. Presynaptic homeostasis at CNS nerve terminals compensates for lack of a key Ca2+ entry pathway. Proceedings of the National Academy of Sciences of the United States of America. 101: 3609-14. PMID 14990796 DOI: 10.1073/Pnas.0308188100  0.354
2003 Roose JP, Diehn M, Tomlinson MG, Lin J, Alizadeh AA, Botstein D, Brown PO, Weiss A. T cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression. Plos Biology. 1: E53. PMID 14624253 DOI: 10.1371/Journal.Pbio.0000053  0.587
2003 Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu IP, Hernandez-Boussard T, Johnson SW, O'Dwyer PJ, et al. Gene expression patterns in ovarian carcinomas. Molecular Biology of the Cell. 14: 4376-86. PMID 12960427 DOI: 10.1091/Mbc.E03-05-0279  0.501
2003 Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, Brown PO. Individuality and variation in gene expression patterns in human blood. Proceedings of the National Academy of Sciences of the United States of America. 100: 1896-901. PMID 12578971 DOI: 10.1073/Pnas.252784499  0.606
2003 Diehn M, Sherlock G, Binkley G, Jin H, Matese JC, Hernandez-Boussard T, Rees CA, Cherry JM, Botstein D, Brown PO, Alizadeh AA. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Research. 31: 219-23. PMID 12519986 DOI: 10.1093/Nar/Gkg014  0.6
2002 Diehn M, Alizadeh AA, Rando OJ, Liu CL, Stankunas K, Botstein D, Crabtree GR, Brown PO. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proceedings of the National Academy of Sciences of the United States of America. 99: 11796-801. PMID 12195013 DOI: 10.1073/Pnas.092284399  0.586
2002 DePrimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, Fero M, Tibshirani R, Brown PO, Brooks JD. Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biology. 3: RESEARCH0032. PMID 12184806 DOI: 10.1186/Gb-2002-3-7-Research0032  0.482
2002 Sayama K, Diehn M, Matsuda K, Lunderius C, Tsai M, Tam SY, Botstein D, Brown PO, Galli SJ. Transcriptional response of human mast cells stimulated via the Fc(epsilon)RI and identification of mast cells as a source of IL-11. Bmc Immunology. 3: 5. PMID 12079505 DOI: 10.1186/1471-2172-3-5  0.465
2002 Lossos IS, Alizadeh AA, Diehn M, Warnke R, Thorstenson Y, Oefner PJ, Brown PO, Botstein D, Levy R. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proceedings of the National Academy of Sciences of the United States of America. 99: 8886-91. PMID 12077300 DOI: 10.1073/Pnas.132253599  0.598
2002 Clément K, Viguerie N, Diehn M, Alizadeh A, Barbe P, Thalamas C, Storey JD, Brown PO, Barsh GS, Langin D. In vivo regulation of human skeletal muscle gene expression by thyroid hormone. Genome Research. 12: 281-91. PMID 11827947 DOI: 10.1101/Gr.207702  0.591
2002 Boldrick JC, Alizadeh AA, Diehn M, Dudoit S, Liu CL, Belcher CE, Botstein D, Staudt LM, Brown PO, Relman DA. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proceedings of the National Academy of Sciences of the United States of America. 99: 972-7. PMID 11805339 DOI: 10.1073/Pnas.231625398  0.584
2002 Sayama K, Diehn M, Matsuda K, Lunderius C, Tsai M, Tam SY, Botstein D, Brown PO, Galli SJ. Transcriptional response of human mast cells stimulated via the Fcε RI and identification of mast cells as a source of IL-11 Bmc Immunology. 3. DOI: 10.1186/1471-2172-3-5  0.369
2001 Diehn M, Eisen MB, Botstein D, Brown PO. From gene expression to the bedside: A high-throughput approach for identifying serum diagnostic markers and immunotherapy targets in human malignancies using DNA microarrays Nature Genetics. 27: 50-50. DOI: 10.1038/87056  0.724
2000 Casagrande R, Stern P, Diehn M, Shamu C, Osario M, Zúñiga M, Brown PO, Ploegh H. Degradation of proteins from the ER of S. cerevisiae requires an intact unfolded protein response pathway. Molecular Cell. 5: 729-35. PMID 10882108 DOI: 10.1016/S1097-2765(00)80251-8  0.425
2000 Diehn M, Alizadeh AA, Brown PO. Examining the living genome in health and disease with DNA microarrays. Jama. 283: 2298-9. PMID 10807394 DOI: 10.1001/Jama.283.17.2298-Jms0503-4-1  0.594
2000 Diehn M, Eisen MB, Botstein D, Brown PO. Large-scale identification of secreted and membrane-associated gene products using DNA microarrays. Nature Genetics. 25: 58-62. PMID 10802657 DOI: 10.1038/75603  0.705
Show low-probability matches.